We studied obesity-related differences in the relation of maternal levels of leptin to levels of soluble fms-like tyrosine kinase 1 (sFlt1), an antiangiogenic protein that influences placentation and risk of adverse pregnancy outcomes. In a prospective cohort of 286 gravidas, we measured maternal serum levels of sFlt1 and leptin at 5 time points across pregnancy. Analyses stratified on prepregnancy body mass index (<25 vs ≥25) were done using mixed linear models. The mean leptin concentrations were significantly higher in overweight/obese compared to normal-weight women, while mean sFlt1 levels in second and third trimester were significantly higher in normal weight compared to overweight/obese women. The relationship between sFlt1 and leptin differed between the 2 strata. After controlling for maternal weight, a 1 ng/mL increase in leptin was associated with an 19.4 pg/mL increase in sFlt1 (P = .01) in normal-weight women, while leptin was not associated with sFlt1 (β = 1.1, P = .75) in overweight/obese women. Such differences suggest that metabolic differences in overweight/obese women compared to their normal weight peers may differentially impact the physiologic changes during pregnancy.
RegnaultTRGalanHLParkerTAAnthonyRV. Placental development in normal and compromised pregnancies—a review. Placenta. 2002;23(suppl A):S119–S129.
2.
SmithGCWearH. The perinatal implications of angiogenic factors. Curr Opin Obstet Gynecol. 2009;21(2):111–116.
3.
MaynardSEpsteinFHKarumanchiSA. Preeclampsia and angiogenic imbalance. Annu Rev Med. 2008;59(1):61–78.
4.
StraughenJKumarPMisraVK. The effect of maternal soluble FMS-like tyrosine kinase 1 during pregnancy on risk of preterm delivery [published online March 27, 2012]. J Matern Fetal Neonatal Med. 2012.
5.
CaoY. Angiogenesis modulates adipogenesis and obesity. J Clin Invest. 2007;117(9):2362–2368.
6.
FriedmanJMHalaasJL. Leptin and the regulation of body weight in mammals. Nature. 1998;395(6704):763–770.
7.
ParkHYKwonHMLimHJPotential role of leptin in angiogenesis: leptin induces endothelial cell proliferation and expression of matrix metalloproteinases in vivo and in vitro. Exp Mol Med. 2001;33(2):95–102.
8.
Sierra-HonigmannMRNathAKMurakamiCBiological action of leptin as an angiogenic factor. Science. 1998;281(5383):1683–1686.
9.
AnagnostoulisSKarayiannakisAJLambropoulouMEfthimiadouAPolychronidisASimopoulosC. Human leptin induces angiogenesis in vivo. Cytokine. 2008;42(3):353–357.
10.
BouloumieADrexlerHCLafontanMBusseR. Leptin, the product of Ob gene, promotes angiogenesis. Circ Res. 1998;83(10):1059–1066.
11.
HighmanTJFriedmanJEHustonLPWongWWCatalanoPM. Longitudinal changes in maternal serum leptin concentrations, body composition, and resting metabolic rate in pregnancy. Am J Obstet Gynecol. 1998;178(5):1010–1015.
12.
MasuzakiHOgawaYSagawaNNonadipose tissue production of leptin: leptin as a novel placenta-derived hormone in humans. Nat Med. 1997;3(9):1029–1033.
13.
HardieLTrayhurnPAbramovichDFowlerP. Circulating leptin in women: a longitudinal study in the menstrual cycle and during pregnancy. Clin Endocrinol (Oxf). 1997;47(1):101–106.
14.
Hauguel-de MouzonSLepercqJCatalanoP. The known and unknown of leptin in pregnancy. Am J Obstet Gynecol. 2006;194(6):1537–1545.
15.
ButteNFHopkinsonJMNicolsonMA. Leptin in human reproduction: serum leptin levels in pregnant and lactating women. J Clin Endocrinol Metab. 1997;82(2):585–589.
16.
SagawaNYuraSItohHPossible role of placental leptin in pregnancy: a review. Endocrine. 2002;19(1):65–71.
17.
MisraVKTrudeauS. The influence of overweight and obesity on longitudinal trends in maternal serum leptin levels during pregnancy. Obesity (Silver Spring). 2011;19(2):416–421.
18.
WHO. Obesity: preventing and managing the global epidemic. Report of a WHO Consultation. Geneva: World Health Organization; 2000.
19.
SelvinSAbramsB. Analysing the relationship between maternal weight gain and birthweight: exploration of four statistical issues. Paediatr Perinat Epidemiol. 1996;10(2):220–234.
20.
HadlockFPHarristRBSharmanRSDeterRLParkSK. Estimation of fetal weight with the use of head, body, and femur measurements—a prospective study. Am J Obstet Gynecol. 1985;151(3):333–337.
StuebeAMMcElrathTFThadhaniREckerJL. Second trimester insulin resistance, early pregnancy body mass index and gestational weight gain. Matern Child Health J. 2010;14(2):254–260.
25.
OuyangYChenHChenH. Reduced plasma adiponectin and elevated leptin in pre-eclampsia. Int J Gynaecol Obstet. 2007;98(2):110–114.
26.
AcromiteMZiotopoulouMOrlovaCMantzorosC. Increased leptin levels in preeclampsia: associations with BMI, estrogen and SHBG levels. Hormones (Athens). 2004;3(1):46–52.
27.
SamolisSPapastefanouIPanagopoulosPGalaziosGKouskoukisAMaroulisG. Relation between first trimester maternal serum leptin levels and body mass index in normotensive and pre-eclamptic pregnancies—role of leptin as a marker of pre-eclampsia: a prospective case-control study. Gynecol Endocrinol. 2010;26(5):338–343.
28.
BaksuAOzkanAGokerNBaksuBUluocakA. Serum leptin levels in preeclamptic pregnant women: relationship to thyroid-stimulating hormone, body mass index, and proteinuria. Am J Perinatol. 2005;22(3):161–164.
29.
LamlTPreyerOHartmannBWRuecklingerESoeregiGWagenbichlerP. Decreased maternal serum leptin in pregnancies complicated by preeclampsia. J Soc Gynecol Investig. 2001;8(2):89–93.
30.
KafulafulaGEMoodleyJOjwangPJKagoroH. Leptin and pre-eclampsia in black African parturients. Bjog. 2002;109(11):1256–1261.
31.
LepercqJGuerre-MilloMAndreJCauzacMHauguel-de MouzonS. Leptin: a potential marker of placental insufficiency. Gynecol Obstet Invest. 2003;55(3):151–155.
32.
WilliamsMAHavelPJSchwartzMWPre-eclampsia disrupts the normal relationship between serum leptin concentrations and adiposity in pregnant women. Paediatr Perinat Epidemiol. 1999;13(2):190–204.
33.
NakatsukasaHMasuyamaHTakamotoNHiramatsuY. Circulating leptin and angiogenic factors in preeclampsia patients. Endocr J. 2008;55(3):565–573.
34.
MisraVKTrudeauSPerniU. Maternal serum lipids during pregnancy and infant birth weight: the influence of prepregnancy BMI. Obesity (Silver Spring). 2011;19(7):1476–1481.
35.
VahratianAMisraVKTrudeauSMisraDP. Prepregnancy body mass index and gestational age-dependent changes in lipid levels during pregnancy. Obstet Gynecol. 2010;116(1):107–113.
36.
UzunHBenianAMadazliRTopcuogluMAAydinSAlbayrakM. Circulating oxidized low-density lipoprotein and paraoxonase activity in preeclampsia. Gynecol Obstet Invest. 2005;60(4):195–200.
37.
MisraVKHobelCJSingCF. The effects of maternal weight gain patterns on term birth weight in African-American women. J Matern Fetal Neonatal Med. 2010;23(8):842–849.
38.
CedergrenMI. Maternal morbid obesity and the risk of adverse pregnancy outcome. Obstet Gynecol. 2004;103(2):219–224.
